SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...

Implementation of novel genetic diagnostic tests is generally driven by technological advances because they promise shorter turnaround times and/or higher diagnostic yields. Other aspects, including ...

Findings suggest the test can reduce the need for PET imaging in some patients with mild cognitive decline to enable therapeutic focus on non-Alzheimer's disease causes, broadening access to quality ...

Please provide your email address to receive an email when new articles are posted on . Increasing diagnoses of paraneoplastic neurologic syndromes in the U.S. correlates to heightened awareness by ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Labcorp Holdings (NYSE:LH) launched the first FDA cleared ...

HOUSTON, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced it will showcase its leadership in pediatric ...

NCD Will Integrate Firefly’s BNA Technology into its Patient Management Protocols for Enhanced Brain Function Insights and Improved Patient Outcomes TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Firefly ...

A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein ...

(MENAFN- AETOSWire) (BUSINESS WIRE ) -- H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully ...

TORONTO, ON / ACCESSWIRE / January 19, 2023 / AVAIL SCIENTIFIC (OTC PINK:MOBO) is pleased to announce it is entering into a letter of intent (LOI) to acquire Florida based Relai Neuro LLC which ...